CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 24 enrolled
Drug / intervention
metformin ER +1 moredrug
Likely dose
metformin ER 850mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00941239
NCT00941239Phase 1Completed
CompareCT.gov

Gastric Tolerability and Pharmacokinetics of an Extended Release Metformin and an Immediate Release Metformin

Laboratorios Silanes S.A. de C.V.·interventional·Posted Jul 17, 2009·Updated Jan 30, 2018

In Brief

A Phase 1 clinical trial evaluating metformin ER and metformin for Healthy. Completed, enrolled 24 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the gastric tolerability and the pharmacokinetics of an extended release metformin compared with an immediate release metformin in healthy subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesMexico
Collaborators--

Timeline

Phase 1CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 17, 2009
Enrollment StartJan 1, 2007
Primary CompletionFeb 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.0 years ago

Interventions

metformin ERdrug

850mg daily for 30 days

metformindrug

850 mg daily for 30 days